UroGen Pharma Ltd.
URGN
22 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 9 4:57 PM | Chris DegnanChief Financial Officer | Sale | 2,202 | $36.69 | $80.8K | 4,561(D) | View → |
| Oct 8, 2026 | Oct 9 10:23 AM | Christopher Degnan | Proposed Sale | 2,202 | $40.70 | $89.6K | — | View → |
| Sep 8, 2026 | Sep 9 6:37 PM | Mark SchoenbergChief Medical Officer | Sale | 871 | $42.92 | $37.4K | 59,882(D) | View → |
| Sep 8, 2026 | Sep 9 6:35 PM | Jason Drew SmithGeneral Counsel | Sale | 1,519 | $42.54 | $64.6K | 53,141(D) | View → |
| Sep 8, 2026 | Sep 9 11:34 AM | Mark Schoenberg | Proposed Sale | 871 | $44.09 | $38.4K | — | View → |
| Sep 8, 2026 | Sep 9 11:34 AM | Jason Smith | Proposed Sale | 1,519 | $44.09 | $67.0K | — | View → |
| Aug 20, 2026 | Aug 24 9:03 PM | Mark SchoenbergChief Medical Officer | Sale | 60,677 | $47.05 | $2.9M | 59,086(D) | View → |
| Aug 20, 2026 | Aug 20 5:24 PM | Schoenberg Mark | Proposed Sale | 60,677 | $47.67 | $2.9M | — | View → |
| Jul 9, 2026 | Jul 10 6:17 PM | Mark SchoenbergChief Medical Officer | Sale | 10,000 | $40.00 | $400.0K | 119,763(D) | View → |
| Jul 9, 2026 | Jul 9 8:19 PM | Schoenberg Mark | Proposed Sale | 10,000 | $40.00 | $400.0K | — | View → |
| Jun 22, 2026 | Jun 24 2:22 PM | Mark SchoenbergChief Medical Officer | Sale | 10,000 | $35.01 | $350.1K | 129,763(D) | View → |
| Jun 22, 2026 | Jun 22 7:53 PM | Schoenberg Mark | Proposed Sale | 10,000 | $35.01 | $350.1K | — | View → |
| Jun 8, 2026 | Jun 9 5:59 PM | Mark SchoenbergChief Medical Officer | Sale | 5,222 | $27.30 | $142.6K | 139,763(D) | View → |
| Jun 8, 2026 | Jun 9 11:50 AM | Schoenberg Mark | Proposed Sale | 5,222 | $26.85 | $140.2K | — | View → |
| May 8, 2026 | May 11 7:54 PM | Mark SchoenbergChief Medical Officer | Sale | 10,000 | $30.00 | $300.0K | 134,985(D) | View → |
| May 8, 2026 | May 8 4:55 PM | Schoenberg Mark | Proposed Sale | 10,000 | $30.00 | $300.0K | — | View → |
| Feb 3, 2026 | Feb 11 7:54 PM | Jason Drew SmithGeneral Counsel | Sale | 7,479 | $19.69 | $147.3K | 55,588(D) | View → |
| Feb 3, 2026 | Feb 5 12:37 AM | Mark SchoenbergChief Medical Officer | Sale | 7,373 | $19.69 | $145.2K | 144,985(D) | View → |
| Feb 2, 2026 | Feb 3 12:53 PM | Schoenberg Mark | Proposed Sale | 13,333 | $19.61 | $261.5K | — | View → |
| Nov 19, 2025 | Nov 19 8:19 PM | Schoenberg Mark | Proposed Sale | 10,000 | $25.00 | $250.0K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 9 4:57 PM | Chris DegnanChief Financial Officer | Option Exercise | 4,483 | — | 4,484(D) | View → |
| Sep 7, 2026 | Sep 9 6:37 PM | Mark SchoenbergChief Medical Officer | Option Exercise | 1,667 | — | 0(D) | View → |
| Sep 7, 2026 | Sep 9 6:35 PM | Jason Drew SmithGeneral Counsel | Option Exercise | 3,334 | — | 0(D) | View → |
| Aug 26, 2026 | Aug 28 8:01 PM | James A. Robinson Jr.Director | Option Exercise | 2,000 | — | 0(D) | View → |
| Jun 22, 2026 | Jun 24 2:03 PM | Daniel George WildmanDirector | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 2:02 PM | James A. Robinson Jr.Director | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 2:01 PM | Stuart HoldenDirector | Grant/Award | 20,000 | $34.99 | 20,000(D) | View → |
| Jun 22, 2026 | Jun 24 2:00 PM | Cynthia M ButittaDirector | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 1:58 PM | Leana WenDirector | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 1:57 PM | Arie BelldegrunDirector | Grant/Award | 20,000 | $34.99 | 20,000(D) | View → |
| Jun 8, 2026 | Jun 9 5:59 PM | Mark SchoenbergChief Medical Officer | Option Exercise | 10,000 | — | 0(D) | View → |
| May 26, 2026 | May 27 12:04 PM | James A. Robinson Jr.Director | Option Exercise | 2,000 | — | 2,000(D) | View → |
| Feb 26, 2025 | Feb 27 9:44 PM | James A. Robinson Jr.Director | Option Exercise | 2,000 | — | 4,000(D) | View → |
| Jan 31, 2026 | Feb 19 3:46 PM | Elizabeth A. BarrettChief Executive Officer | Grant/Award | 153,195 | — | 153,195(D) | View → |
| Jan 31, 2026 | Feb 11 7:54 PM | Jason Drew SmithGeneral Counsel | Grant/Award | 32,609 | — | 32,609(D) | View → |
| Jan 31, 2026 | Feb 11 7:54 PM | Jason Drew SmithGeneral Counsel | Option Exercise | 15,500 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 10:18 PM | Mark SchoenbergChief Medical Officer | Grant/Award | 20,000 | — | 20,000(D) | View → |
| Jan 31, 2026 | Feb 3 10:18 PM | Mark SchoenbergChief Medical Officer | Option Exercise | 13,333 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 10:16 PM | Chris DegnanChief Financial Officer | Grant/Award | 32,609 | — | 32,609(D) | View → |